FDA Adverse Event Injury Summary report: N

BD U F II 3/10CC 31G SYRINGE

MDR report key: 1219491 · Received October 31, 2008

Report

Report Number
1920898-2008-00024
Event Type
Injury
Date Received
October 31, 2008
Date of Event
October 4, 2008
Report Date
October 30, 2008
Manufacturer
BECTON DICKINSON
Product Code
FMF
PMA / PMN Number
K024112
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

EVALUATION SUMMARY: ISSUE - PLUNGER OF SYRINGE WAS OBSERVED TO MOVE FREELY WITHOUT RESISTANCE DURING INJECTION AND AFTER INJECTION, BLOOD GLUCOSE LEVELS STARTED TO GO UP. REPORT: REGULATORY COMPLIANCE RECEIVED ONE (1) LOOSE 3/10CC SYRINGE WHICH CUSTOMER CLAIMS WHILE INJECTION WITH THIS SYRINGE, THE PLUNGER MOVED DOWN FREELY WITH NO RESISTANCE AT ALL AND FOLLOWING INJECTION, BLOOD GLUCOSE LEVELS ROSE. THE CUSTOMER GAVE THE LOT# FOR THIS PRODUCT AS 8141664. THE SYRINGE WAS VISUALLY EXAMINED, AND NO ISSUES WERE OBSERVED. THE CANNULA WAS INSPECTED ALONG THE INJECTION LENGTH, FOR ANY CRACKS OR DAMAGE, BUT THE CANNULA WAS FOUND TO BE INTACT. THE SYRINGE WAS FURTHER EXAMINED UNDER UV LIGHT, AND THERE WAS SUFFICIENT ADHESIVE OBSERVED IN HUB; THEREFORE, NO LEAKAGE COULD TAKE PLACE THERE. THE SUSTAINING FORCE WAS THEN MEASURED AND WAS FOUND TO BE WITHIN SPECIFICATION. FOLLOWING THIS, THE INNER DIAMETER OF THE CANNULA WAS CAREFULLY WIRED TO SEE IF IT WAS BLOCKED AS THIS COULD CAUSE A BUILD UP OF PRESSURE WHICH AFFECTS THE MOVEMENT OF THE PLUNGER. THE WIRE WENT THROUGH TO OTHER END WITHOUT ANY ISSUES. FINALLY, THE SYRINGE WAS EVALUATED BY DRAWING THE EXPELLING INSULIN AND THE SYRINGE PERFORMED AS PER SPECIFICATION. NO DEFECTS WERE FOUND OR NOTED WITH THE RETURNED SYRINGE. A DEVICE HISTORY REVIEW WAS ALSO CONDUCTED AND NO ANOMALIES WERE NOTED. REGULATORY COMPLIANCE WILL CONTINUE TO MONITOR ON MONTHLY TREND REPORTS.

Description of Event or Problem · 1

CUSTOMER REPORTS NOTICING THAT THE PLUNGER OF THE SYRINGE BEING USED FOR AN INSULIN INJECTION, MOVED DOWN FREELY WITHOUT ANY RESISTANCE. THEN, AFTER INJECTION, THE BLOOD GLUCOSE LEVEL STARTED TO GO UP. A CALL WAS MADE TO THE DOCTOR WHO ADVISED THAT AN ADDITIONAL FOUR (4) UNITS OF INSULIN BE INJECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BD U F II 3/10CC 31G SYRINGE INSULIN SYRINGE FMF BECTON DICKINSON NA 8141664

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention